HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naoki Yoshimura Selected Research

Urinary Bladder Diseases (Bladder Diseases)

1/2014Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome.
8/2009Induction of apoptosis in human bladder cancer cells by green tea catechins.
2/2009Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitis.
5/2004Sustained intravesical drug delivery using thermosensitive hydrogel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naoki Yoshimura Research Topics

Disease

38Inflammation (Inflammations)
01/2022 - 01/2002
34Spinal Cord Injuries (Spinal Cord Injury)
06/2022 - 11/2002
28Interstitial Cystitis (Interstitial Cystitis, Chronic)
03/2022 - 01/2002
27Overactive Urinary Bladder (Overactive Bladder)
01/2022 - 11/2002
25Pain (Aches)
03/2022 - 01/2002
23Stress Urinary Incontinence
01/2020 - 12/2003
20Cystitis
01/2022 - 05/2002
18Ulcerative Colitis
04/2022 - 01/2003
16Sneezing
01/2020 - 08/2003
9Neoplasms (Cancer)
01/2022 - 01/2002
9Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2022 - 10/2005
9Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 10/2005
8Underactive Urinary Bladder
01/2022 - 01/2014
8Crohn Disease (Crohn's Disease)
01/2021 - 08/2014
8Ataxia (Dyssynergia)
01/2021 - 01/2004
8Hemorrhage
08/2020 - 06/2010
8Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
05/2018 - 04/2006
7Heart Failure
09/2022 - 10/2005
7Fibrosis (Cirrhosis)
06/2022 - 08/2017
6Neurogenic Urinary Bladder (Bladder, Neurogenic)
11/2020 - 08/2003
6Hypersensitivity (Allergy)
01/2019 - 10/2008
6Wounds and Injuries (Trauma)
11/2017 - 10/2007
5Congenital Heart Defects (Congenital Heart Defect)
01/2018 - 05/2003
5Abnormal Reflex (Hyperreflexia)
09/2011 - 11/2002
4Ischemia
12/2021 - 08/2017
4Neuralgia (Stump Neuralgia)
03/2021 - 01/2016
4Hypertrophy
05/2018 - 10/2006
4Body Weight (Weight, Body)
06/2016 - 06/2003
4Parkinson Disease (Parkinson's Disease)
05/2016 - 08/2003
4Infections
01/2015 - 03/2004
4Urinary Bladder Diseases (Bladder Diseases)
01/2014 - 05/2004
4Ventricular Heart Septal Defects (Ventricular Septal Defect)
12/2006 - 12/2002
3Diabetes Mellitus
12/2021 - 09/2002
3Lower Urinary Tract Symptoms
12/2020 - 11/2006
3Colitis
01/2018 - 04/2015

Drug/Important Bio-Agent (IBA)

18Nerve Growth Factor (NGF)IBA
06/2022 - 09/2002
18Messenger RNA (mRNA)IBA
12/2021 - 10/2007
17Pharmaceutical PreparationsIBA
06/2022 - 11/2002
15Capsaicin (Zostrix)FDA Link
01/2019 - 11/2002
14CytokinesIBA
10/2021 - 10/2005
12Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2015 - 05/2004
11Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2002
10salicylhydroxamic acid (SHAM)IBA
01/2017 - 09/2005
9Therapeutic UsesIBA
12/2021 - 02/2008
9Formaldehyde (Formol)FDA Link
01/2021 - 04/2014
9Type A Botulinum Toxins (Botox)FDA Link
01/2017 - 10/2004
7Adrenergic Receptors (Adrenergic Receptor)IBA
01/2020 - 02/2007
6Liposomes (Liposome)IBA
12/2021 - 01/2014
6Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2009
6Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 01/2017
6Muscarinic AntagonistsIBA
10/2020 - 02/2005
6Tadalafil (Cialis)FDA Link
01/2020 - 10/2014
6ProstaglandinsIBA
11/2019 - 02/2006
6Botulinum Toxins (Botulinum Toxin)IBA
02/2017 - 11/2002
5Cadherins (E-Cadherin)IBA
01/2022 - 01/2019
5Infliximab (Remicade)FDA Link
01/2021 - 05/2013
5CollagenIBA
11/2020 - 08/2017
5Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2017 - 02/2005
5Cholinergic Antagonists (Anticholinergics)IBA
01/2017 - 01/2003
5Acetic Acid (Vinegar)FDA LinkGeneric
12/2016 - 09/2002
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 09/2004
5Urethane (Ethyl Carbamate)IBA
09/2015 - 08/2003
5EnzymesIBA
03/2015 - 01/2002
4SteroidsIBA
06/2022 - 04/2004
4Antisense OligonucleotidesIBA
12/2021 - 08/2013
4Adalimumab (Humira)FDA Link
01/2021 - 11/2016
4Cholinergic Agents (Cholinergics)IBA
01/2021 - 03/2008
4Interleukin-6 (Interleukin 6)IBA
09/2020 - 04/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2020 - 10/2005
4Phosphodiesterase 5 InhibitorsIBA
01/2020 - 08/2017
42-mercaptopurineIBA
09/2019 - 05/2013
4suplatast tosilateIBA
01/2019 - 05/2002
4resiniferatoxinIBA
01/2018 - 01/2003
4Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2015 - 02/2007
3Adrenal Cortex Hormones (Corticosteroids)IBA
06/2022 - 04/2004
3Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2022 - 01/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 05/2003
3ElastinIBA
11/2020 - 08/2017
3Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2020 - 05/2002
3Streptozocin (Streptozotocin)FDA Link
05/2020 - 09/2002
3Transforming Growth Factor beta (TGF-beta)IBA
01/2020 - 01/2002
3Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2020 - 08/2017
3Adenosine Triphosphate (ATP)IBA
01/2020 - 07/2004
3Dinoprostone (PGE2)FDA Link
11/2019 - 03/2011
3Azathioprine (Imuran)FDA LinkGeneric
09/2019 - 11/2016
3Analgesics (Analgesic Drugs)IBA
03/2019 - 04/2007
3AntibodiesIBA
01/2019 - 11/2002
3ChemokinesIBA
01/2018 - 09/2010
3Serotonin ReceptorsIBA
01/2018 - 07/2008

Therapy/Procedure

47Therapeutics
06/2022 - 05/2002
9Intravesical Administration
01/2022 - 02/2005
8Drug Therapy (Chemotherapy)
07/2021 - 12/2003
7Cardiopulmonary Bypass (Heart-Lung Bypass)
09/2022 - 01/2002
7Thoracotomy
03/2021 - 01/2009
7Blood Component Removal (Apheresis)
11/2020 - 01/2003
5Anesthesia
03/2022 - 12/2006
5Catheters
01/2018 - 08/2003
4Ligation
07/2021 - 05/2008
3Conservative Treatment
08/2020 - 02/2017
3Lasers (Laser)
01/2018 - 04/2015